XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 29.81

-4.2%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (5033)	12/8/1997 11:43:00 AM
From: aknahow	Read Replies (2) of 17367

Yep, Jesse Eisenger did it again. Quality article on IDEC in The Street. No mention of Xoma. E-mailed Eisenger not to ask about XOMA but to ask about royalties and sub royalties and why exact percents are not disclosed when material. Copied XOMA, but don't know if that wrks or not. Forgot to put attention E. Martin on it, so may never get there. I am going to begin e-mailing more decision makers not to ask what they think about Xoma but generic issues which are related to XOMA. Eisenger mentioned U.S. launch on 22 of Dec. M.L. estimate of sales 1 st yr $140 million and co est. of $175 million. Peak sales yr is given as $400 million.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next